PHAM
RDY icon

Portland Hill Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Portland Hill Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$906K Sell
61,760
-2,715
-4% -$39.6K 2.21% 13
2023
Q4 		$863K Hold
64,475
– – 2.25% 13
2023
Q3 		$857K Sell
64,475
-8,615
-12% -$117K 2.21% 13
2023
Q2 		$902K Sell
73,090
-9,080
-11% -$106K 2.13% 12
2023
Q1 		$946K Sell
82,170
-1,485
-2% -$16K 2.21% 13
2022
Q4 		$858K Sell
83,655
-2,055
-2% -$22.2K 2.38% 13
2022
Q3 		$958K Sell
85,710
-2,785
-3% -$29.7K 1.79% 15
2022
Q2 		$967K Sell
88,495
-9,450
-10% -$103K 1.31% 14
2022
Q1 		$1.09M Sell
97,945
-4,825
-5% -$54.7K 0.99% 14
2021
Q4 		$1.34M Sell
102,770
-22,325
-18% -$281K 1.02% 15
2021
Q3 		$1.63M Buy
125,095
+615
+0.5% +$8.2K 1.08% 15
2021
Q2 		$1.83M Buy
124,480
+2,665
+2% +$37.3K 1.08% 15
2021
Q1 		$1.49M Sell
121,815
-2,210
-2% -$28.4K 1.01% 14
2020
Q4 		$1.75M Sell
124,025
-2,555
-2% -$34.4K 1.23% 15
2020
Q3 		$1.77M Buy
126,580
+1,525
+1% +$18.2K 1.47% 14
2020
Q2 		$1.31M Buy
125,055
+3,325
+3% +$33.8K 1.33% 14
2020
Q1 		$999K Sell
121,730
-13,360
-10% -$111K 1.29% 14
2019
Q4 		$1.09M Sell
135,090
-67,395
-33% -$532K 1.11% 15
2019
Q3 		$1.54M Sell
202,485
-2,680
-1% -$19.9K 1.23% 13
2019
Q2 		$1.54M Sell
205,165
-31,520
-13% -$248K 1.13% 15
2019
Q1 		$1.91M Sell
236,685
-43,250
-15% -$329K 1.37% 15
2018
Q4 		$2.1M Sell
279,935
-36,195
-11% -$255K 1.42% 15
2018
Q3 		$2.21M Sell
316,130
-50,435
-14% -$337K 0.95% 16
2018
Q2 		$2.39M Buy
366,565
+5,720
+2% +$36.1K 1.01% 17
2018
Q1 		$2.36M Buy
360,845
+82,985
+30% +$582K 1.03% 18
2017
Q4 		$2.1M Sell
277,860
-8,100
-3% -$58.3K 0.97% 16
2017
Q3 		$2.04M Sell
285,960
-28,445
-9% -$205K 1.01% 16
2017
Q2 		$2.65M Sell
314,405
-11,250
-3% -$91.5K 1.35% 16
2017
Q1 		$2.63M Sell
325,655
-5,510
-2% -$47.6K 1.38% 20
2016
Q4 		$3M Buy
+331,165
New +$3.08M 1.8% 17

Other funds holding RDY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Portland Hill Asset Management's RDY Position: Q1 2024 in Review

Portland Hill Asset Management reduced its Dr. Reddy's Laboratories (RDY) stake by 4.2% in Q1 2024, selling an estimated $39.6K and leaving 61,760 shares worth $906K. The position accounts for 2.21% of the portfolio, ranked #13.

Portland Hill Asset Management first reported a position in RDY in Q4 2016 and has held it in 30 quarters since. The position peaked at $3M in Q4 2016. 231 funds tracked by Wall St. Rank hold RDY as of Q1 2024.

  • Portland Hill Asset Management held 61,760 shares of Dr. Reddy's Laboratories worth $906K as of Q1 2024.
  • Portland Hill Asset Management sold 2,715 Dr. Reddy's Laboratories shares in Q1 2024, an estimated $39.6K.
  • Dr. Reddy's Laboratories made up 2.21% of Portland Hill Asset Management's portfolio in Q1 2024, its #13 holding.
  • Portland Hill Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2016 and has held it in 30 quarters since.
  • Portland Hill Asset Management's Dr. Reddy's Laboratories position peaked at $3M in Q4 2016.
  • 231 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2024.

Based on Portland Hill Asset Management's 13F filing for Q1 2024, filed 15 May 2024.